Company Filing History:
2 out of 560 
1 out of 8 Years Active: 2025
Title: Ivo Lorenz: Innovator in Cancer Therapy
Introduction
Ivo Lorenz is a prominent inventor based in New York, NY, known for his significant contributions to cancer therapy. With a total of two patents, he has made strides in the field of immunology and cancer treatment.
Latest Patents
His latest patents include "DLL3-targeting antibodies and uses thereof," which focuses on immunoglobulin-related compositions that can bind to delta-like protein 3 (DLL3). These antibodies are instrumental in detecting and treating DLL3-associated cancers. Another notable patent is "Compositions and methods for adoptive cell therapy for cancer," which details methods for adoptive cell therapy using engineered immune cells that express a tumor antigen-targeted chimeric antigen receptor and a prodrug converting enzyme.
Career Highlights
Ivo Lorenz has worked with esteemed organizations such as Memorial Sloan Kettering Cancer Center and the Tri-Institutional Therapeutics Discovery Institute. His work in these institutions has been pivotal in advancing cancer research and therapy.
Collaborations
He has collaborated with notable colleagues, including David A. Scheinberg and Thomas J. Gardner, contributing to innovative research and development in cancer treatment.
Conclusion
Ivo Lorenz's work and patents reflect his dedication to improving cancer therapies through innovative approaches. His contributions are vital in the ongoing fight against cancer, showcasing the importance of research and collaboration in this field.